Cart
sales@molnova.com
5-Methoxytryptamine
CAS No. 608-07-1
5-Methoxytryptamine( 3-(2-Aminoethyl)-5-methoxyindole | O-Methylserotonin )
Catalog No. M20020 CAS No. 608-07-1
5-Methoxytryptamine is a tryptamine derivative that acts as a full agonist at the 5-HT1 5-HT2 5-HT4 5-HT6 and 5-HT7 receptors.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 26 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name5-Methoxytryptamine
-
NoteResearch use only, not for human use.
-
Brief Description5-Methoxytryptamine is a tryptamine derivative that acts as a full agonist at the 5-HT1 5-HT2 5-HT4 5-HT6 and 5-HT7 receptors.
-
Description5-Methoxytryptamine is a tryptamine derivative that acts as a full agonist at the 5-HT1 5-HT2 5-HT4 5-HT6 and 5-HT7 receptors.
-
In Vitro——
-
In Vivo——
-
Synonyms3-(2-Aminoethyl)-5-methoxyindole | O-Methylserotonin
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
Recptor5-HT
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number608-07-1
-
Formula Weight190.24
-
Molecular FormulaC11H14N2O
-
Purity>98% (HPLC)
-
SolubilityDMSO:200 mM
-
SMILESCOc1ccc2[nH]cc(CCN)c2c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bacon WL et al. 5-Hydroxytryptamine(7) receptor activation decreases slow afterhyperpolarization amplitude in CA3 hippocampal pyramidal cells. J Pharmacol Exp Ther. 2000 Aug;294(2):672-9.
molnova catalog
related products
-
Cinitapride
Cinitapride is a gastroprokinetic agent. It slows the actions of the muscles to reduce the symptoms of conditions such as acid reflux, delayed gastric emptying, and ulcer dyspepsia.
-
Perlapine
Perlapine (AW-14233;HF-2333;Hypnodine) is a potent antihistamine that has high affinity for dopamine D1, α1, α2 and 5-HT2A receptors.
-
Elbasvir
Elbasvir is an inhibitor of nonstructural protein 5A (NS5A) of hepatitis C virus (HCV) being developed as a component of treatment regimens for chronic HCV infection.
